SG Americas Securities LLC Buys 7,387 Shares of Dolby Laboratories $DLB

SG Americas Securities LLC boosted its position in Dolby Laboratories (NYSE:DLB) by 157.4% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,079 shares of the electronics maker’s stock after purchasing an additional 7,387 shares during the quarter. SG Americas Securities LLC’s holdings in Dolby Laboratories were worth $897,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in shares of Dolby Laboratories by 7.8% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 15,777 shares of the electronics maker’s stock valued at $1,172,000 after buying an additional 1,146 shares in the last quarter. Police & Firemen s Retirement System of New Jersey lifted its position in Dolby Laboratories by 7.0% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 23,145 shares of the electronics maker’s stock valued at $1,719,000 after acquiring an additional 1,516 shares during the last quarter. Geode Capital Management LLC boosted its stake in Dolby Laboratories by 2.0% in the second quarter. Geode Capital Management LLC now owns 1,556,571 shares of the electronics maker’s stock valued at $116,159,000 after acquiring an additional 30,057 shares in the last quarter. Vise Technologies Inc. acquired a new stake in Dolby Laboratories in the second quarter valued at approximately $276,000. Finally, Allworth Financial LP grew its holdings in Dolby Laboratories by 590.4% in the second quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock worth $37,000 after purchasing an additional 431 shares during the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

DLB has been the subject of several analyst reports. Baird R W upgraded Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Barrington Research decreased their price target on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research note on Wednesday, November 19th. Rosenblatt Securities lowered their price target on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a report on Wednesday. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Tigress Financial increased their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a research report on Friday, August 15th. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Dolby Laboratories currently has an average rating of “Moderate Buy” and an average price target of $92.00.

Insider Buying and Selling at Dolby Laboratories

In other news, CEO Kevin J. Yeaman sold 25,000 shares of the stock in a transaction dated Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total transaction of $1,721,750.00. Following the sale, the chief executive officer directly owned 114,725 shares of the company’s stock, valued at $7,901,110.75. This represents a 17.89% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 38.39% of the company’s stock.

Dolby Laboratories Stock Up 3.1%

Dolby Laboratories stock opened at $67.52 on Monday. The business’s 50-day moving average price is $68.59 and its 200 day moving average price is $72.34. The firm has a market cap of $6.47 billion, a price-to-earnings ratio of 24.73 and a beta of 0.97. Dolby Laboratories has a 52 week low of $64.02 and a 52 week high of $89.66.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29. The company had revenue of $307.02 million during the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.Dolby Laboratories’s revenue for the quarter was up .7% on a year-over-year basis. During the same period in the previous year, the company posted $0.61 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS. Equities analysts expect that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd will be issued a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 2.1%. Dolby Laboratories’s dividend payout ratio is presently 54.75%.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.